Alabama STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.

Press releases published on October 24, 2026

2 hours ago

2026 National Poppy Campaign launches with a donation “first” … and stunning mural: Don’t forget to Remember

Indeterminate GlobeNewswire

3 hours ago

JelluTide Gummies Introduces Jellu Tide Multi-Ingredient Dietary Supplement Formulation

Indeterminate GlobeNewswire

3 hours ago

Quanta Presents Positive Clinical Combination Data in KRAS G12D-Mutant CRC at ESMO and Highlights Pan-KRAS Progress

Indeterminate GlobeNewswire

3 hours ago

Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors

Indeterminate GlobeNewswire

3 hours ago

DEEP Robotics Unveils Five Research Advances in Embodied AI

Indeterminate GlobeNewswire

3 hours ago

XBiotech gibt die Wahl von Sushma Shivaswamy und Jan-Paul Simard zu Co-Chief Executive Officers bekannt

Indeterminate GlobeNewswire

3 hours ago

XBiotech annonce la nomination de Sushma Shivaswamy et Jan-Paul Simard aux postes de co-directeurs généraux

Indeterminate GlobeNewswire

4 hours ago

NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma

Indeterminate GlobeNewswire

4 hours ago

NANOBIOTIX annonce les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle immunitaires chez des patients atteints de mélanome cutané résistant aux anti-PD-1, en traitement de de…

Indeterminate GlobeNewswire

7 hours ago

Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

Indeterminate GlobeNewswire

7 hours ago

Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026

Indeterminate GlobeNewswire

9 hours ago

Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence

Indeterminate GlobeNewswire

9 hours ago

Darolutamidi yhdessä ADT- ja sädehoidon kanssa vähensi 58 prosentilla syövän leviämisen tai kuoleman vaaraa potilailla, joilla on suuri eturauhassyövän uusiutumisen riski

Indeterminate GlobeNewswire

9 hours ago

Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting

Indeterminate GlobeNewswire

9 hours ago

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

Indeterminate GlobeNewswire

9 hours ago

Yangguang News Launches Global Youth Short Video Campaign “Me, Tang Poetry, and AI”

Indeterminate GlobeNewswire

12 hours ago

Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma

Indeterminate GlobeNewswire

13 hours ago

Vmake Labs Launches All-in-One Halloween Social Video Toolkit for SMBs

Indeterminate GlobeNewswire